TrialBlood2019
Adjuvant low-dose rituximab and plasma exchange for acquired TTP.
Jeffrey I Zwicker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
TrialBlood2019
Jeffrey I Zwicker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.